Organigram Holdings Stock Performance
| OGI Stock | USD 1.89 0.02 1.07% |
OrganiGram Holdings has a performance score of 2 on a scale of 0 to 100. The company holds a Beta of 3.26, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, OrganiGram Holdings will likely underperform. OrganiGram Holdings right now holds a risk of 6.11%. Please check OrganiGram Holdings total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to decide if OrganiGram Holdings will be following its historical price patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in OrganiGram Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain technical and fundamental indicators, OrganiGram Holdings may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
Last Split Factor 1:4 | Last Split Date 2023-07-07 |
1 | Organigram Shares Down 4.8 percent - MarketBeat | 02/07/2024 |
2 | Will OrganiGram Holdings Inc Stay at the Top of the Healthcare Sector - InvestorsObserver | 02/28/2024 |
3 | Closing Bell Organigram Holdings Inc up on Friday - Barchart | 03/08/2024 |
4 | Is OrganiGram Holdings Inc Stock a Good Value Friday - InvestorsObserver | 03/15/2024 |
5 | Analyst Rating Will OrganiGram Holdings Inc Stock Outperform the Market - InvestorsObserver | 03/19/2024 |
6 | ORGANIGRAM HLDGS INC. Trade Ideas MUN0OG0 TradingView - TradingView | 03/26/2024 |
7 | Why OrganiGram Might Surprise This Earnings Season | 03/28/2024 |
8 | Organigram Given a C5.25 Price Target by ATB Capital Analysts - Defense World | 04/04/2024 |
9 | EXCLUSIVE Fifteen New F1 Hybrid Cannabis Strains To Hit Shelves In US For 420 Under New Partnership | 04/10/2024 |
10 | Closing Bell Organigram Holdings Inc down on Wednesday - The Globe and Mail | 04/17/2024 |
| Begin Period Cash Flow | 68.5 M | |
| Total Cashflows From Investing Activities | 4.6 M |
OrganiGram |
OrganiGram Holdings Relative Risk vs. Return Landscape
If you would invest 190.00 in OrganiGram Holdings on January 21, 2024 and sell it today you would lose (1.00) from holding OrganiGram Holdings or give up 0.53% of portfolio value over 90 days. OrganiGram Holdings is generating 0.1722% of daily returns assuming volatility of 6.1059% on return distribution over 90 days investment horizon. In other words, 53% of stocks are less volatile than OrganiGram, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
OrganiGram Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for OrganiGram Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as OrganiGram Holdings, and traders can use it to determine the average amount a OrganiGram Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0282
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OGI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.11 actual daily | 54 54% of assets are less volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average OrganiGram Holdings is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OrganiGram Holdings by adding it to a well-diversified portfolio.
OrganiGram Holdings Fundamentals Growth
OrganiGram Stock prices reflect investors' perceptions of the future prospects and financial health of OrganiGram Holdings, and OrganiGram Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OrganiGram Stock performance.
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0556 | ||||
| Profit Margin | (1.54) % | ||||
| Operating Margin | (0.44) % | ||||
| Current Valuation | 140.54 M | ||||
| Shares Outstanding | 103 M | ||||
| Price To Earning | (79.96) X | ||||
| Price To Book | 1.06 X | ||||
| Price To Sales | 1.35 X | ||||
| Revenue | 149.21 M | ||||
| Gross Profit | 35.07 M | ||||
| EBITDA | (88.23 M) | ||||
| Net Income | (229.48 M) | ||||
| Cash And Equivalents | 127.36 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 4.72 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 4.17 X | ||||
| Book Value Per Share | 3.18 X | ||||
| Cash Flow From Operations | (35.19 M) | ||||
| Earnings Per Share | (1.82) X | ||||
| Market Capitalization | 195.23 M | ||||
| Total Asset | 298.45 M | ||||
| Retained Earnings | (538.53 M) | ||||
| Working Capital | 166.34 M | ||||
| Current Asset | 204.52 M | ||||
| Current Liabilities | 54.43 M | ||||
About OrganiGram Holdings Performance
To evaluate OrganiGram Holdings Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when OrganiGram Holdings generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare OrganiGram Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand OrganiGram Holdings market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents OrganiGram's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 218.16 | 207.25 | |
| Return On Tangible Assets | (0.03) | (0.03) | |
| Return On Capital Employed | (0.07) | (0.08) | |
| Return On Assets | (0.02) | (0.03) | |
| Return On Equity | (0.03) | (0.03) |
Things to note about OrganiGram Holdings performance evaluation
Checking the ongoing alerts about OrganiGram Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OrganiGram Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OrganiGram Holdings had very high historical volatility over the last 90 days | |
| OrganiGram Holdings may become a speculative penny stock | |
| The company reported the last year's revenue of 149.21 M. Reported Net Loss for the year was (229.48 M) with profit before taxes, overhead, and interest of 35.07 M. | |
| OrganiGram Holdings has about 127.36 M in cash with (35.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| OrganiGram Holdings has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Closing Bell Organigram Holdings Inc down on Wednesday - The Globe and Mail |
- Analyzing OrganiGram Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OrganiGram Holdings' stock is overvalued or undervalued compared to its peers.
- Examining OrganiGram Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OrganiGram Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of OrganiGram Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OrganiGram Holdings' stock. These opinions can provide insight into OrganiGram Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.Note that the OrganiGram Holdings information on this page should be used as a complementary analysis to other OrganiGram Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for OrganiGram Stock analysis
When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is OrganiGram Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.